ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MERC Mercia Asset Management Plc

29.50
0.00 (0.00%)
Last Updated: 07:32:18
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mercia Asset Management Plc LSE:MERC London Ordinary Share GB00BSL71W47 ORD 0.001P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 29.50 29.00 30.00 29.50 29.50 29.50 52,058 07:32:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 25.88M 2.84M - N/A 0
Mercia Asset Management Plc is listed in the Finance Services sector of the London Stock Exchange with ticker MERC. The last closing price for Mercia Asset Management was 29.50p. Over the last year, Mercia Asset Management shares have traded in a share price range of 21.00p to 35.60p.

Mercia Asset Management currently has 440,810,454 shares in issue.

Mercia Asset Management Share Discussion Threads

Showing 776 to 799 of 1525 messages
Chat Pages: Latest  37  36  35  34  33  32  31  30  29  28  27  26  Older
DateSubjectAuthorDiscuss
06/5/2020
10:08
Hidden value and it will stay largely hidden until it’s realised, hence the buying opportunity, but always DYOR.
gwr7
06/5/2020
09:23
how are they getting on with their stakes in Impression, medherant and nDreams, i wonder?
mw8156
06/5/2020
09:11
Oxgene doubling revenues
Collaboration with Native Antigen
MERC with 30%in both (maybe more now for Oxgene)

mr.oz
06/5/2020
09:10
Yes, good that they're talking about investing for the medium to long term for this fast growing company. Also good that Canaccord are involved as Mercia's large stake could have put other instis off.
gwr7
06/5/2020
08:40
Excellent Indeed andyview


Mercia Asset Management PLC
@Mercia_PLC
ยท
50m
Mercia invests £1.0million as part of a £3.0million syndicated investment into OXGENE. Read the full details including comments from
@MPayton_Mercia
Mark Payton - Mercia Asset Management here -

cheshire man
06/5/2020
08:28
I’ve decided to add a few more, MERC have provided £1 mill of the new funding totalling £3 mill.

Liked this it too:

OXGENE™ has worked with global partners including Abcam plc for the delivery of over 1,000 CRISPR engineered cell lines, Artios Pharma, who are developing breakthrough cancer treatments, and The Native Antigen Company (also a Mercia direct investment) to accelerate the production of COVID-19 antigens.


Gla

andyview
06/5/2020
08:16
More excellent news out today, gla
andyview
04/5/2020
15:06
NAC :quite a shining star for MERC.
Will be very interested in how their value is growing

mr.oz
04/5/2020
12:50
I think the interaction between Concepta and Abingdon shows the benefit of Mercia’s involvement in both companies.
gwr7
04/5/2020
10:23
Indeed, every positive ingredient/development helps.

I note also that another Mercia portfolio company, MIP Diagnostics, has entered into a COVID-19 testing collaboration -

Stream Bio collaborates with MIP Diagnostics Ltd. on a rapid diagnostic and mass screening test for COVID-19

wan
04/5/2020
08:51
All grist to the mill. Concepta have a licence to use Abingdon's app so Abingdon will get a royalty from Concepta sales.
gwr7
04/5/2020
08:22
I think this is intriguing
And ambitious

mr.oz
04/5/2020
07:20
According to today's news, Abigndon Health find Concepta and the Femtech opportunity interesting enough to enter into a partnership -

Concepta PLC Partnership agreement with Abingdon Health
04/05/2020 7:00am
RNS Non-Regulatory

wan
03/5/2020
22:16
Concepta are outsourcing manufacturing to Abingdon Health. The latter will gain from manufacturing capacity that wasn't being utilised. I don't think Concepta is one of the more interesting companies in Mercia's portfolio.
gwr7
02/5/2020
09:06
Recently Mercia supported and took part in a placing for Concepta at 0.08p. Concepta are indirectly connected with recent Coronavirus developments at Abingdon Health. I note that there has since been a spike in volumes and an increase in Concepta's share price, and yesterday the shares jumped over 30% on strong volume and no news!
wan
01/5/2020
14:07
I’ve added a few more, solid investment case imho

Gla

andyview
01/5/2020
11:45
Thanks GWR! Still practicing in the garden, that Dabizas turn still works, and my son is picking up the reins

Good info, cheers,

D

dennisbergkamp
01/5/2020
11:29
We've signed the best player I've seen in the premiership now. Nice one Dennis. I'm not expecting fireworks but we have strong asset backing and I do expect a re-rating. The covid companies will establish the business model and set us up for years. They're looking to be evergreen by 2022 ie. new direct portfolio buys and existing company development funding rounds are covered by value realisation, either by IPO or company sales.
gwr7
01/5/2020
10:33
Looks very interesting as an indirect way to cover a number of companies helping the cause

D

dennisbergkamp
01/5/2020
10:06
Also, Abingdon Healthcare are a partner in the RTC with Omega.
longshanks
01/5/2020
08:30
Apologies if I didn't make the connection with Omega clear. MERC have a significant holding in The Native Antigen Company who are making reagents for use in the antibody test being developed by Omega and the British consortium partners. Both Omega and the NAC will gain big time from the approval of the test anticipated in June/July. There has been some positive news in the last 24 hours. Oxford University's Professor John Bell, who led the assessment of imported tests that were shown to be innacurate, gave a positive update on channel 4 news saying the British consortium was world leading. Also ODX have moved quickly to expand their premises.
gwr7
01/5/2020
08:09
Anyone got an idea of how omega holding likely to affect current nav given its rise?
its the oxman
30/4/2020
16:33
Approx £50k mopped up at the close of play
mr.oz
30/4/2020
12:18
My pleasure Mr Richardson. Like longshanks I know a bit about Omega. I’m convinced the consortium will produce an antibody test though nobody can say when and the government was late getting the ball rolling. Development started in April when it could easily have been February. We know from experience that it can take years to achieve a fully approved POC test. A lot of that is tortuous regulatory hurdles which now vanish like the morning mist when the government has a crisis on it’s hands and they’re aiming to produce the test in June/July. One of the positives that will come out of this is more focus on diagnostics in the UK which will benefit the whole sector. It’s been a crying shame and all the delays have caused unnecessary death but by investing in the companies involved, rather than trading, we are making a difference. I could pull out of Omega now with a 500% gain but I’m holding after covering my initial purchase. Once we get the POC test it will be a boost for MERC. I don’t even think it needs to be a consortium test as the high tech manufacturers will still be involved due to the numbers required. I’d prefer it to be an entirely Made in Britain test though. Goodness knows we deserve it.
gwr7
Chat Pages: Latest  37  36  35  34  33  32  31  30  29  28  27  26  Older

Your Recent History

Delayed Upgrade Clock